Fig. 2 | Signal Transduction and Targeted Therapy

Fig. 2

From: A Kaposi’s sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy

Fig. 2

Increased kshv-miR-K12-1-5p level and KSHV prevalence were associated with poor prognosis of DCM. a A flowchart of the plasma cohort study. b Survival curves for the primary endpoint across kshv-miR-K12-1-5p quartiles. Q1, the first (lowest) quartile; Q2, the second quartile; Q3, the third quartile; Q4, the fourth (highest) quartile. c Survival curves for the primary endpoint for DCM patients with KSHV DNA seronegativity or seropositivity

Back to article page